JPMorgan Chase & Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$69.9M Sell
2,639,055
-487,447
-16% -$12.9M ﹤0.01% 1038
2025
Q1
$75.5M Buy
3,126,502
+968,959
+45% +$23.4M 0.01% 977
2024
Q4
$86.8M Buy
2,157,543
+41,105
+2% +$1.65M 0.01% 909
2024
Q3
$134M Sell
2,116,438
-135,233
-6% -$8.56M 0.01% 777
2024
Q2
$119M Buy
2,251,671
+1,211,513
+116% +$64.2M 0.01% 777
2024
Q1
$85.3M Buy
1,040,158
+472,566
+83% +$38.8M 0.01% 935
2023
Q4
$10.6M Buy
567,592
+10,424
+2% +$194K ﹤0.01% 2071
2023
Q3
$6.17M Buy
557,168
+10,635
+2% +$118K ﹤0.01% 2301
2023
Q2
$8.86M Buy
546,533
+543,895
+20,618% +$8.82M ﹤0.01% 2121
2023
Q1
$43.7K Buy
2,638
+2,140
+430% +$35.4K ﹤0.01% 4943
2022
Q4
$4K Sell
498
-28,510
-98% -$229K ﹤0.01% 5275
2022
Q3
$80K Sell
29,008
-17,077
-37% -$47.1K ﹤0.01% 4553
2022
Q2
$134K Buy
46,085
+13,192
+40% +$38.4K ﹤0.01% 4509
2022
Q1
$99K Buy
32,893
+5,606
+21% +$16.9K ﹤0.01% 4755
2021
Q4
$124K Buy
27,287
+1,152
+4% +$5.24K ﹤0.01% 4742
2021
Q3
$164K Sell
26,135
-737
-3% -$4.63K ﹤0.01% 4498
2021
Q2
$160K Sell
26,872
-12,551
-32% -$74.7K ﹤0.01% 4583
2021
Q1
$251K Buy
39,423
+9,623
+32% +$61.3K ﹤0.01% 4371
2020
Q4
$167K Buy
29,800
+5,358
+22% +$30K ﹤0.01% 4195
2020
Q3
$145K Buy
24,442
+2,390
+11% +$14.2K ﹤0.01% 3892
2020
Q2
$159K Buy
22,052
+597
+3% +$4.31K ﹤0.01% 3773
2020
Q1
$101K Buy
21,455
+20
+0.1% +$94 ﹤0.01% 3933
2019
Q4
$172K Hold
21,435
﹤0.01% 3867
2019
Q3
$147K Buy
21,435
+3,611
+20% +$24.8K ﹤0.01% 3864
2019
Q2
$149K Buy
17,824
+2,983
+20% +$24.9K ﹤0.01% 3874
2019
Q1
$148K Sell
14,841
-479
-3% -$4.78K ﹤0.01% 3867
2018
Q4
$117K Buy
15,320
+3,309
+28% +$25.3K ﹤0.01% 3986
2018
Q3
$209K Buy
12,011
+3,168
+36% +$55.1K ﹤0.01% 3858
2018
Q2
$84K Buy
+8,843
New +$84K ﹤0.01% 4136